Introduction
Somatotropin (GH) and insulin have opposite effects in glucose and lipids metabolism and synergic effects in the promotion of protein synthesis. In a healthy individual, in the postprandial period, insulin is the most important anabolic hormone as it promotes glucose and lipids storage. During fasting, the action of GH predominates, switching the preferential energetic substrate through stimulation of lipolysis and sparing the stored proteins. Through this mechanism, GH increases plasmatic free fatty acids and ketone bodies concentration, promoting hepatic and peripheral insulin resistance (Table 1) .
Conclusion:
Diabetic ketoacidosis is a very rare event in patients with acromegaly (1%). In our patients, its prevalence was 6,4% (N=47). In cases 1 and 2, initial GH secretion was very high and GH reduction led to a significant improvement in metabolic control. In case 3, glycemic control worsened probably due to the iatrogenic effect of prednisolone in a pancreas recently exposed to the glucolipotoxicity caused by GH. Somatotropin effects in carbohydrate metabolism and in the appearance of diabetic ketoacidosis in acromegaly are complex and not totally understood, but may be reversible with the reduction or normalization of GH levels. 
Acromegaly
• Lipolysis and glyconeogenesis induced by GH may lead to decreased pancreatic insulin secretion, changes in the expression of the insulin gene and increased beta cell apoptosis.
• If insulin production is not able to counterbalance the increased insulin resistance, glucose intolerance or diabetes may appear. Rarely, when there is a relative/absolut insulin deficit and an excess of counterregulatory hormones, diabetic ketoacidosis may occur.
• The severity of glucose metabolism disturbance may be related to GH plasmatic concentrations (>25ng/ml). Clinical cases (Table 2) Tabela 1 -Main metabolic effects of insulin, GH and IGF-1 
